Handmade quality · Free shipping over $75 · Explore the atelier

RVX-208 - BET Bromodomain Inhibitor. CAS# 1044870-39-4 60428 InChiKey: UZIATSFXNVOVFE-OAHLLOKOSA-N

SKU: 51028606187

4.4
USD39.00 USD62.00

Pay in 4 interest-free payments of $9.75 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

InChiKey: UZIATSFXNVOVFE-OAHLLOKOSA-N

Potent and Selective Inhibition of Histone Deacetylase 6 (HDAC6) Does Not Require a Surface-Binding Motif

Smiles: CC(C1CCN(CC1)S(=O)(=O)CC)N1C2=CC=CC=C2C(C(=O)NCC2=C(C=C(C)NC2=O)OC)=C1C

SCR7: a NHEJ inhibitor promotes the efficiency of HDR 4–5-fold for CRISPR editing in both human and mouse cell lines

Smiles: C/C(=N\NC(=S)N1CCC1)/C1=CC=CC=N1

RVX-208 - BET Bromodomain Inhibitor. CAS# 1044870-39-4 60428 InChiKey: UZIATSFXNVOVFE-OAHLLOKOSA-NRVX 208, CAS No. 1044870 39 4, also known as Apabetalone, is a potent inhibitor of BET bromodomains. RVX 208 functions by removing atherosclerotic plaque via reverse cholesterol transport (RCT). RVX 208 increases the production of ApoA I in hepatocytes in vitro, and in vivo in monkeys and humans, which results in increased HDL C, but the molecular target was not previously reported. RVX 208 may be a promising new approach to the treatment of

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products